Cargando…
Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8
Purpose: Vitiligo is a T cell-mediated skin depigmentation disease. Though treatments arresting disease progression and inducing repigmentation are available, the efficacy of these options is often limited and poorly sustained. How stromal signals contribute to the interferon-γ-dominant skin niches...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856695/ https://www.ncbi.nlm.nih.gov/pubmed/36672151 http://dx.doi.org/10.3390/cells12020217 |
_version_ | 1784873695977668608 |
---|---|
author | Jin, Rong Zhou, Miaoni Lin, Fuquan Xu, Wen Xu, Aie |
author_facet | Jin, Rong Zhou, Miaoni Lin, Fuquan Xu, Wen Xu, Aie |
author_sort | Jin, Rong |
collection | PubMed |
description | Purpose: Vitiligo is a T cell-mediated skin depigmentation disease. Though treatments arresting disease progression and inducing repigmentation are available, the efficacy of these options is often limited and poorly sustained. How stromal signals contribute to the interferon-γ-dominant skin niches is unclear. This study aims to determine how fibroblasts participate in the IFN-γ-dominant vitiligo niche. Patients and methods: Mouse vitiligo models were established. Fibroblasts from control and vitiligo mice were extracted for RNA sequencing. In vitro IFN-γ stimulation was performed to verify the JAK-STAT pathway by qPCR and Western blot. T cell polarization with chemokines was measured by flow cytometry. Protein levels in tissues were also examined by IHC. Results: The vitiligo mouse model recapitulates the human CD8-IFN-γ pathway. RNA sequencing revealed elevated chemokine CCL2 and CCL8 in vitiligo fibroblast, which may be regulated by the JAK-STAT signaling. Such phenomenon is verified by JAK inhibitor peficitinib in vitro. Moreover, CCL2 addition into the naïve T polarization system promoted type 2 cytokines secretion, which represents a hallmark of vitiligo lesions. Conclusion: Dermal fibroblasts, a principal constituent of skin structure, respond to IFN-γ by skewing T cells towards a type 2 cytokine profile via CCL2 and CCL8, which can be abrogated by JAK inhibitor peficitinib. |
format | Online Article Text |
id | pubmed-9856695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98566952023-01-21 Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 Jin, Rong Zhou, Miaoni Lin, Fuquan Xu, Wen Xu, Aie Cells Article Purpose: Vitiligo is a T cell-mediated skin depigmentation disease. Though treatments arresting disease progression and inducing repigmentation are available, the efficacy of these options is often limited and poorly sustained. How stromal signals contribute to the interferon-γ-dominant skin niches is unclear. This study aims to determine how fibroblasts participate in the IFN-γ-dominant vitiligo niche. Patients and methods: Mouse vitiligo models were established. Fibroblasts from control and vitiligo mice were extracted for RNA sequencing. In vitro IFN-γ stimulation was performed to verify the JAK-STAT pathway by qPCR and Western blot. T cell polarization with chemokines was measured by flow cytometry. Protein levels in tissues were also examined by IHC. Results: The vitiligo mouse model recapitulates the human CD8-IFN-γ pathway. RNA sequencing revealed elevated chemokine CCL2 and CCL8 in vitiligo fibroblast, which may be regulated by the JAK-STAT signaling. Such phenomenon is verified by JAK inhibitor peficitinib in vitro. Moreover, CCL2 addition into the naïve T polarization system promoted type 2 cytokines secretion, which represents a hallmark of vitiligo lesions. Conclusion: Dermal fibroblasts, a principal constituent of skin structure, respond to IFN-γ by skewing T cells towards a type 2 cytokine profile via CCL2 and CCL8, which can be abrogated by JAK inhibitor peficitinib. MDPI 2023-01-04 /pmc/articles/PMC9856695/ /pubmed/36672151 http://dx.doi.org/10.3390/cells12020217 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jin, Rong Zhou, Miaoni Lin, Fuquan Xu, Wen Xu, Aie Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title | Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title_full | Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title_fullStr | Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title_full_unstemmed | Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title_short | Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8 |
title_sort | pathogenic th2 cytokine profile skewing by ifn-γ-responding vitiligo fibroblasts via ccl2/ccl8 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856695/ https://www.ncbi.nlm.nih.gov/pubmed/36672151 http://dx.doi.org/10.3390/cells12020217 |
work_keys_str_mv | AT jinrong pathogenicth2cytokineprofileskewingbyifngrespondingvitiligofibroblastsviaccl2ccl8 AT zhoumiaoni pathogenicth2cytokineprofileskewingbyifngrespondingvitiligofibroblastsviaccl2ccl8 AT linfuquan pathogenicth2cytokineprofileskewingbyifngrespondingvitiligofibroblastsviaccl2ccl8 AT xuwen pathogenicth2cytokineprofileskewingbyifngrespondingvitiligofibroblastsviaccl2ccl8 AT xuaie pathogenicth2cytokineprofileskewingbyifngrespondingvitiligofibroblastsviaccl2ccl8 |